Healius Limited ACN 064 530 516Corporate Governance Statement 2026Supporting better health outcomes for Australians2026 Corporate Governance StatementOverviewThe ASX Corporate Governance Council has published corporate governance principles and recommendations for ASX listed entities (ASX...
2026 Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Healius
- 2026 Annual Report
- Appointment of Company Secretary
- Ceasing to be a substantial holder
- Change in substantial holding
- Notice of 2026 Annual General Meeting
Later from Healius
- 2026 Appendix 4G
- Becoming a substantial holder
- Trading Halt
- Agreement to sell Agilex Biolabs to Novotech
Follow Healius into a list and get an email when it puts out news.
Follow Healius